Application Sponsors
ANDA 209700 | TEVA PHARMS USA | |
Marketing Status
Discontinued | 001 |
Discontinued | 002 |
Application Products
001 | TABLET;ORAL | 7MG | 0 | TERIFLUNOMIDE | TERIFLUNOMIDE |
002 | TABLET;ORAL | 14MG | 0 | TERIFLUNOMIDE | TERIFLUNOMIDE |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2018-09-04 | STANDARD |
LABELING; Labeling | SUPPL | 2 | AP | 2022-07-15 | STANDARD |
Submissions Property Types
CDER Filings
TEVA PHARMS USA
cder:Array
(
[0] => Array
(
[ApplNo] => 209700
[companyName] => TEVA PHARMS USA
[docInserts] => ["",""]
[products] => [{"drugName":"TERIFLUNOMIDE","activeIngredients":"TERIFLUNOMIDE","strength":"7MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"TERIFLUNOMIDE","activeIngredients":"TERIFLUNOMIDE","strength":"14MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"09\/04\/2018","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2018-09-04
)
)